Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Gallium Maltolate is a Promising Chemotherapeutic Agent for the Treatment of Hepatocellular Carcinoma

MEI-SZE CHUA, LAWRENCE R. BERNSTEIN, RUI LI and SAMUEL K.S. SO
Anticancer Research May 2006, 26 (3A) 1739-1743;
MEI-SZE CHUA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mchua{at}stanford.edu
LAWRENCE R. BERNSTEIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RUI LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAMUEL K.S. SO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 26 no. 3A 1739-1743
PMID 
16827101

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 15, 2006
  • Accepted February 24, 2006
  • Published online May 1, 2006.

Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MEI-SZE CHUA1,
  2. LAWRENCE R. BERNSTEIN2,
  3. RUI LI1 and
  4. SAMUEL K.S. SO1
  1. 1Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305-5655
  2. 2Terrametrix, 285 Willow Road, Menlo Park, CA 94025-2711, U.S.A.
  1. Correspondence to: Mei-Sze Chua, 300 Pasteur Drive, H3680, Department of Surgery, Stanford, CA 94305-5655, U.S.A. Tel: 1-650-724-3525, e-mail:mchua{at}stanford.edu

Statistics from Altmetric.com

Cited By...

  • 68 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 3A
May-June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gallium Maltolate is a Promising Chemotherapeutic Agent for the Treatment of Hepatocellular Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Gallium Maltolate is a Promising Chemotherapeutic Agent for the Treatment of Hepatocellular Carcinoma
MEI-SZE CHUA, LAWRENCE R. BERNSTEIN, RUI LI, SAMUEL K.S. SO
Anticancer Research May 2006, 26 (3A) 1739-1743;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Gallium Maltolate is a Promising Chemotherapeutic Agent for the Treatment of Hepatocellular Carcinoma
MEI-SZE CHUA, LAWRENCE R. BERNSTEIN, RUI LI, SAMUEL K.S. SO
Anticancer Research May 2006, 26 (3A) 1739-1743;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Metal speciation in blood plasma
  • Cellular uptake and anticancer activity of carboxylated gallium corroles
  • Combination of Three Metals for the Treatment of Cancer: Gallium, Rhenium and Platinum. 1. Determination of the Optimal Schedule of Treatment
  • Gallium Maltolate Treatment Eradicates Pseudomonas aeruginosa Infection in Thermally Injured Mice
  • Inhibition of the Proteasome Activity by Gallium(III) Complexes Contributes to Their Anti Prostate Tumor Effects
  • Development of Gallium Compounds for Treatment of Lymphoma: Gallium Maltolate, a Novel Hydroxypyrone Gallium Compound, Induces Apoptosis and Circumvents Lymphoma Cell Resistance to Gallium Nitrate
  • Google Scholar

More in this TOC Section

  • Implications of the Cuproptosis Protein SLC31A1 for the Immune Microenvironment and Temozolomide Sensitivity in Glioblastoma
  • Y-box Binding Protein 1 as a Target Molecule of a Novel Coumarin-based Anti-metastatic Agent
  • Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire